Bonus: CNS Summit Call on the Impact of COVID-19 Crisis on Clinical Trials
This is a special episode of a webinar that was recorded on Friday, May 8, 2020.
In this recording, we hear from Dr. Amy Abernethy, Principal Deputy Commissioner and Acting CIO of the FDA, as she speaks with Dr Amir Kalali, Chief Curator of CNS Summit.
Drs. Abernethy and Kalali discuss:
- How Covid-19 is impacting drug development
- How the FDA is aligning and responding to the pandemic
- Unexpected ways the pandemic may influence clinical research and medicine
For more podcasts like this, be sure to subscribe to the CNS Summit Podcast on Apple Podcasts, Google Podcasts or Spotify, and you can also find us on Health Podcast Network at HealthPodcastNetwork.com